Prognostic impact of preprocedural C reactive protein levels on 6-month angiographic and 1-year clinical outcomes after drug-eluting stent implantation
- 1 September 2007
- Vol. 93 (9), 1087-1092
- https://doi.org/10.1136/hrt.2006.099762
Abstract
Objective: To determine the association of preprocedural C reactive protein (CRP) levels with angiographic restenosis and adverse clinical events after drug-eluting stent (DES) implantation. Design: A prospective cohort analysis of preprocedural CRP levels as a predictor of serious ischaemic complications or binary restenosis in patients treated with DES. Setting: Tertiary referral centre. Patients: 1650 consecutive patients who underwent successful DES implantation. Patients were grouped into tertiles according to preprocedural CRP values for data analysis. Interventions: Successful DES implantation. Main outcome measures: The primary end point was a major coronary event, defined as cardiac death or Q-wave myocardial infarction. Results: Baseline clinical and angiographic characteristics were similar between the tertile groups, except that more patients had multivessel disease and acute coronary syndrome with increasing tertiles of CRP levels. At 1-year follow-up, a primary end point occurred in 4 (0.7%) patients of the lowest tertile, in 3 (0.5%) patients of the middle tertile and in 16 (2.9%) patients of the highest tertile (p = 0.003). In multivariate analysis, the highest tertile of CRP levels was an independent predictor of a major coronary event (HR 4.68, 95% CI 1.91 to 11.44, tertile III vs tertiles I and II, p = 0.001). However, restenosis rates were similar in all three groups (9.1% vs 11.4% vs 11.6%, respectively, p = 0.3). Conclusions: Preprocedural CRP levels are significantly associated with major coronary events after DES implantation. However, preprocedural CRP levels do not predict subsequent restenosis. Baseline CRP levels may be useful to guide adjunctive management for preventing serious ischaemic events in patients undergoing DES implantation.Keywords
This publication has 23 references indexed in Scilit:
- C-Reactive Protein, Clinical Outcome, and Restenosis Rates After Implantation of Different Drug-Eluting StentsThe American Journal of Cardiology, 2006
- A Polymer-Based, Paclitaxel-Eluting Stent in Patients with Coronary Artery DiseaseThe New England Journal of Medicine, 2004
- Sirolimus-Eluting Stents versus Standard Stents in Patients with Stenosis in a Native Coronary ArteryThe New England Journal of Medicine, 2003
- Association between C-Reactive protein levels and subsequent cardiac events among patients with stable angina treated with coronary artery stentingAmerican Journal Of Medicine, 2003
- Clinical Application of C-Reactive Protein for Cardiovascular Disease Detection and PreventionCirculation, 2003
- Comparison of C-Reactive Protein and Low-Density Lipoprotein Cholesterol Levels in the Prediction of First Cardiovascular EventsThe New England Journal of Medicine, 2002
- The impact of plasma levels of C-reactive protein, lipoprotein (a) and homocysteine on the long-term prognosis after successful coronary stenting: The global evaluation of new events and restenosis after stent implantation studyJournal of the American College of Cardiology, 2002
- A Randomized Comparison of a Sirolimus-Eluting Stent with a Standard Stent for Coronary RevascularizationThe New England Journal of Medicine, 2002
- Preprocedural C-reactive protein levels and cardiovascular events after coronary stent implantationJournal of the American College of Cardiology, 2001
- Preprocedural serum levels of C-reactive protein predict early complications and late restenosis after coronary angioplastyJournal of the American College of Cardiology, 1999